Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Table 2 Pattern of expression of Id1 and Id3 proteins in the 17 evaluable patients

Patient number	Tissue	Staining intensity		Percentage of staining		H-score
Patient number	Tissue	Id1	Id3	Id1	Id3	Id1	Id3
10	LB	1	0	2	0	2	0
2	BB	2	1	3	1	6	1
3	BB	2	2	1	1	2	2
5	BB	1	1	1	1	1	1
6	BB	1	1	2	1	2	1
7	BB	2	1	2	2	4	2
8	BB	1	0	3	0	3	0
1	LNB	3	3	3	2	9	6
11	LNB	0	0	0	0	0	0
4	CB	0	0	0	0	0	0
9	CB	1	0	2	0	2	0
12	C	0	0	0	0	0	0
13	C	1	0	2	0	2	0
14	C	0	0	0	0	0	0
15	C	1	0	2	0	2	0
16	C	1	0	1	0	1	0
17	C	1	1	2	1	2	1

Tissue sample: LB (lung biopsy), BB (bronchial biopsy), LNB (lymph node biopsy), CB (cell block sample), C (cytology sample). Staining intensity (0: no staining, 1: weak, 2: moderate, 3: strong staining). Percentage of staining (0 = 0%, 1 = 0-5%, 2 = 5-50%, 3 > 50%).

ISSN: 1479-5876